ArticleMolecular cancer therapeutics2022

Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment.

Shu Ning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.